Bill Gates Optimistic Of Progress In TB Vaccine Clinical Trial - NEWS AGENCY OF NIGERIA
Bill Gates expresses optimism in the M72 tuberculosis vaccine's clinical trial, hoping for 70% efficacy. The trial, costing $500 million and done in collaboration with GSK and Wellcome Trust, aims to be the first new TB vaccine in over a century.
Reference News
Bill Gates Optimistic Of Progress In TB Vaccine Clinical Trial - NEWS AGENCY OF NIGERIA
Bill Gates expresses optimism in the M72 tuberculosis vaccine's clinical trial, hoping for 70% efficacy. The trial, costing $500 million and done in collaboration with GSK and Wellcome Trust, aims to be the first new TB vaccine in over a century.